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Skeletal muscle satellite cells, located between the
basal lamina and plasma membrane of myofibers,
are required for skeletal muscle regeneration. The
capacity of satellite cells as well as other cell lineages
includingmesoangioblasts,mesenchymal stemcells,
and side population (SP) cells to contribute tomuscle
regeneration has complicated the identification of
a satellite stem cell. We have characterized a rare
subset of the muscle SP that efficiently engrafts into
the host satellite cell niche when transplanted into
regenerating muscle, providing 75% of the satellite
cell population and 30% of the myonuclear popula-
tion, respectively. These cells are found in the satellite
cell position, adhere to isolated myofibers, and
spontaneously undergo myogenesis in culture. We
propose that this subset of SP cells (satellite-SP
cells), characterized by ABCG2, Syndecan-4, and
Pax7 expression, constitutes a self-renewing muscle
stem cell capable of generating both satellite cells
and their myonuclear progeny in vivo.
INTRODUCTION
Maintenance and repair of skeletal muscle tissue is essential for
survival of locomotor organisms. Although satellite cells are
thought to be the primary source of new myonuclei during skel-
etal muscle growth and repair, the engraftment capability of iso-
lated satellite cells into injured or diseased skeletalmuscle is poor
(Asakura et al., 2007; Montarras et al., 2005; Beauchamp et al.,
1999). Indeed, cells derived from other sources including meso-
angioblasts (Sampaolesi et al., 2003, 2006), pericytes (Dellavalle
et al., 2007), and bone marrow stem cells (Gussoni et al., 1999;
LaBarge and Blau, 2002) engraft into myofibers with greater
efficiency than isolated satellite cells. Only a subset of muscle
cells enriched for CD34 expression by cell sorting is capable of
engraftment into skeletal muscle myofibers and into the host
satellite cell niche (Montarras et al., 2005; Cerletti et al., 2008;
Saccoet al., 2008). Althoughefficient atmyonuclear engraftment,
these cells engraft with much lower frequencies into the satellite
cell niche. These observations, together with data demonstratingasymmetric division of satellite cells (Kuang et al., 2007) and
satellite cell heterogeneity (Olguin and Olwin, 2004; Zammit
et al., 2004), suggest that a rare population of satellite cells may
exist with enhanced stem cell-like characteristics.
Many adult tissues, including bone marrow (Goodell et al.,
1996), heart (Asakura et al., 2002), lung (Majka et al., 2005), and
skeletal muscle (Majka et al., 2003), possess cells that exhibit
the SP phenotype. Indeed, the discovery of these cells in skeletal
muscle and their myogenic potential suggested they may func-
tion as satellite cell progenitors; however, the low efficiency of
muscle SP cell engraftment into skeletal muscle suggested that
this population was not representative of a skeletal muscle
progenitor (Muskiewicz et al., 2005). Here, we show that a subset
of the muscle SP cells that possess both SP and satellite cell
characteristics function as efficient satellite cell progenitors.
Although the majority of SP cells reside in the interstitium (Mee-
son et al., 2004), satellite-SP cells (1) can be found in the satellite
cell position, (2) remain associated with isolated myofibers, (3)
spontaneously fuse in culture, and (4) generate satellite cell
progeny in vivo, all characteristics consistent with a satellite cell
progenitor. Evidence that a subpopulation of satellite cells may
function as a reserve or progenitor population was described
using in vivo labeling techniques more than three decades ago
(reviewed in Schultz, 1996). Recently, the demonstrations of
satellite cell heterogeneity (Olguin and Olwin, 2004; Zammit
et al., 2004), coupledwith identity of a small population of satellite
cells that exhibits asymmetric cell division (Kuang et al., 2007),
and long-termBrdU retention (Shinin et al., 2006), all characteris-
tics of stem cells, have further strengthened this idea.
RESULTS
Skeletal Muscle SP Cells Express Syndecan-3
and Syndecan-4
When examining data frommicroarray analyses of Syndecan-3+/
Syndecan-4+ cells isolated by fluorescence-activated cell sorting
(FACS) from uninjured muscle, we found high-level expression of
both Abcg2 and Cd34. This expression is dramatically reduced
in cells sorted from BaCl2-injured muscles, 24 hr postinjury
(Figure 1A, and see Table S1 available online). The high-level
expression of these cell markers, coupled with their differential
expression following injury, prompted us to examine ABCG2 and
CD34 protein expression in the satellite cell population. Although
others have successfully observed CD34 immunoreactivity inCell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc. 217
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Syndecan-4 SP Cells Engraft as Satellite CellsFigure 1. A Subset of Skeletal Muscle SP Cells Expresses the Satel-
lite Cell Markers Syndecan-4 and Syndecan-3
Relative expression levels of genes obtained frommicroarray data from FACS-
purified Syndecan-3+/Syndecan-4+ satellite cells isolated from uninjured
muscles (black) and muscles 24 hr after BaCl2 injury (gray) and filtered for
selected stem cell genes: the Abcg family, Cd34, nanog, and the satellite
cell-specific genes sdc3 and sdc4 ([A], probe sets ordered 50 to 30). Live-cell
FACS profiles for bone marrow-derived cells (B–D) and skeletal muscle-
derived cells (E–I) incubated with Hoescht 33342 in the presence (C and F)
and absence (B, D, E, and G–I) of verapamil to identify the SP gate (R3 regions
with cell percentages noted). More than 90% of SP cells from both tissues
express the ABCG2 transporter (D and G), gray histogram with ABCG2 anti-
body, and (H) using the Abcg2/GFP mouse (Tadjali et al., 2006), while the
majority of main population cells located above the SP gate do not express
ABCG2 ([G], hatched histogram). A subpopulation of muscle SP cells also
expresses the satellite cell markers Syndecan-4 and Syndecan-3 ([I],
R4 region) as identified by costaining with antibodies during SP profiling. (J)
A Venn diagram depicting the percent of Syndecan-3+/Syndecan-4+ muscle
SP cells within the cohort of all cells in the entire hindlimb muscle tissue and
within the context of muscle SP cells. Percentages of individual cell popula-
tions are noted. Background gates were set with less than 0.5% of controls
scored as positive.218 Cell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc.satellite cells, in our hands the staining patterns were highly vari-
able and inconsistent (data not shown), and thus we focused
on ABCG2.
ABCG2 is theATP-binding cassette transporter responsible for
the majority of the SP phenotype originally characterized in bone
marrow (Goodell et al., 1996; Zhou et al., 2001). Therefore, we
asked if skeletal muscle cells expressing Syndecan-4, which
marks all Pax7+ and c-met+ satellite cells (Cornelison et al.,
2001; Brack et al., 2007; Bosnakovski et al., 2008), also express
ABCG2protein using an anti-ABCG2antibody. First, to verify that
the anti-ABCG2antibody identifies cells exhibiting theSPpheno-
type, we performed FACS analysis of bone marrow cells using
Hoechst 33342 dye efflux to identify SP cells (R3 in Figures 1B
and 1C) and compared the SP cells identified by dye efflux with
those identified by anti-ABCG2 immunoreactivity. ABCG2 immu-
noreactive cells comprised 90%–95% of the SP cell population,
confirming the utility of the ABCG2 antibody for identifying
SP cells (Figure 1D). Although the majority of bone marrow SP
cells are ABCG2+, multiple ABC transporters contribute to the
SPphenotype, and thus the entire SP is not ABCG2 immunoreac-
tive (Zhou et al., 2001). In hindlimb skeletal muscle, we identified
SP cells by dye efflux that comprised 1%–5% of total hindlimb
cells (Figures 1E and 1F, R3 region), similar to that reported by
others (Montanaro et al., 2004). The majority (90%) of these
SP cells are ABCG2 immunoreactive (Figure 1G, gray). To further
verify the utility of the ABCG2 antibody, we examined cells
located above the SP gate in the main population, which are
generally not ABCG2 immunoreactive (Figure 1G, hatched).
Finally, we isolated SP cells using Hoescht dye exclusion from
a mouse expressing GFP from an IRES-GFP knocked into the
third intron of the Abcg2 locus (Tadjali et al., 2006). These cells
are both GFP+ and anti-GFP immunoreactive, confirming that
the anti-ABCG2 antibody recognizes cells expressing Abcg2
(Figure 1H). We then examined muscle SP cells isolated by dye
exclusion for satellite cell markers by FACS and found that 5%–
10% of hindlimb SP cells are immunoreactive for the satellite
cellmarkers Syndecan-3 andSyndecan-4 (Figure 1I). This subset
of hindlimb cells represented in the Venn diagram is a subfraction
of the SP that expresses the satellite cell marker Syndecan-4
(Figure 1J). To allow detection of additional markers and to alle-
viate the damaging effects of the Hoescht 33342 dye, we used
anti-ABGG2 immunoreactivity to identify and isolate muscle SP
cells except where noted.
A Subset of Satellite Cells Is SP Cells
To further characterize the Syndecan-3+/Syndecan-4+ SP cells,
we analyzed mononuclear cells from mouse hindlimb muscle
tissue by FACS using the anti-ABCG2 antibody. Of the entire
population of mononuclear cells in the hindlimb (Figure 2A),
10%–20% are Syndecan-4 immunoreactive (Figure 2B), and all
Syndecan-4+cells are viable (Figure 2C). To verify that thesecells
are not significantly contaminated by cells from the blood and
endothelial lineages, we profiled for CD45, Gr-1, Mac-1, Thy-1,
and PECAM-1. The blood cell markers were not expressed
by Syndecan-4+ cells isolated from skeletal muscle (Figures
2D–2G). Prior reports suggest that satellite cells as well as endo-
thelial cells express PECAM-1 (CD31) (De Angelis et al., 1999),
and we found a similar small percentage of Syndecan-4+ cells
(7% of all Syndecan-4+ cells) and Syndecan-4+/ABCG2+ cells
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Syndecan-4 SP Cells Engraft as Satellite CellsFigure 2. Satellite-SP Cells Express the
Stem Cell Markers ABCG2 and Sca1
Live-cell FACS profiles for hindlimb skeletal
muscle (A–L) identify a population of Syndecan-
4+ satellite cells in the total events ([A], FSC/
forward scatter and SSC/side scatter), plotted as
events versus Syndecan-4 fluorescence intensity
to resolve Syndecan-4+ cells ([B], black profile)
from background ([B], gray profile). Live cells
convert fluorescein diacetate to FITC, showing
the majority of Syndecan-4+ cells are viable ([C],
region R6). Syndecan-4+ cells are negative for
the blood linage makers CD45 (D), Gr-1 (E), Mac-
1 (F), and Thy-1 (G), and 7% Syndecan4+ cells
express PECAM-1 (H). Profiling simultaneously
for three markers on live cells, we identified
a subset of Syndecan-4+ cells that express the
stem cell markers ABCG2 ([I], R11) and Sca1 ([J],
R15). Approximately 7% of the hindlimb muscle-
derived cells express both ABCG2 and Sca1 ([K],
R19), and this subset of ABCG2+/Sca1+ cells
represents 3% of Syndecan-4+ cells ([L], R19).
A satellite-SP cell (inset in [M] –[P]) in a 3D recon-
structionofmuscle section fromaconfocalZ series
is located underneath the basal lamina ([M], red)
and immunoreactive for ABCG2 ([N] and [P],
cyan) and Syndecan-4 ([O] and [P], white). The
inset (M–P) is a magnified region of the boxed
area. (Q) A Venn diagram depicts the percentage
of Syndecan-4+, ABCG2+, and dual positive cells
represented in collagenase-digested hindlimb
muscle. Freshly isolated myofibers retain rare
satellite-SP cells ([R]–[U], caret) immunoreactive
for ABCG2 ([R], red, caret), Sca1 ([S], green, caret),
and Syndecan-4 ([T], white, caret); DNA is counter-
stained with DAPI ([R], [S], and [U], blue). In addi-
tion, note the ABCG2-negative Syndecan-4+
satellite cell on this fiber ([R]–[U], arrow), where
DAPI is not bright in thisplaneof focus. In (B) and (D–H), blackhistograms represent specific antibody immunoreactivity, andgrayhistogramsare thecorresponding
control. In (A)–(L), all gateswere determined by setting controls at less than 0.5%positive events. For (M)–(P), the scale bar represents 75 mm, and for (R)–(U), 1 mm.(8% of all dually positive satellite cells) express PECAM-1
(Figure 2H, Figure S1). We then profiled for three markers simul-
taneously—Syndecan-4, ABCG2, and Sca1, another stem cell
marker previously identified on SP cells (Asakura et al., 2002;
Jackson et al., 1999; Mitchell et al., 2005). As expected, the
majority of ABCG2+ cells and Sca1+ cells are Syndecan-4
(Figure 2I, R10, and Figure 2J, R14, respectively). Consistent
with the SP cell data (see Figure 1), we found that a population
of Syndecan-4+ cells is immunoreactive for ABCG2 (Figure 2I,
R11) and for Sca1 (Figure 2J, R15). Themajority of ABCG2+ cells
appear Sca1+ (Figure 2K, R19), and this ABCG2+/Sca1+ popula-
tion is enriched in the ABCG2+/Syndecan-4+ cell population
where virtually all Syndecan-4+/ABCG2+ cells are Sca1+
(Figure 2L, R19 compared to R21) and half of the Syndecan-4+/
Sca1+ cells are ABCG2+ (Figure 2L, R18 compared to R19).
This subset of satellite cells is rare, comprising 0.25% of the
entire hindlimb mononuclear cell population (Figure 2Q), and
averages between 3% and 10% of the Syndecan-4+ satellite
cell population.
If these ABCG2+/Sca1+/Syndecan-4+ cells are satellite cells,
they should reside in the satellite cell position in muscle sections
and be retained on intact myofibers following myofiber isolation
by enzymatic digestion. We found rare cells in the satellite cellposition underneath the basal lamina (Figure 2M, inset) immuno-
reactive for Syndecan-4 and ABCG2 (Figures 2N–2P, inset).
Some of these cells were found tightly associated with freshly
isolated myofibers (Figures 2R–2U, carets). Although the
percentages from the FACS profiles suggest that one to two
Syndecan-4+/ABCG2+ SP cells are present on a typical myo-
fiber (assuming 25 satellite cells per myofiber), when fixed
and stained we detect fewer cells than expected (0.5–1/myo-
fiber), likely due to the low expression of ABCG2. These cells
were also Sca1+ (Figure 2S, caret), strongly suggesting that
they represent the cells observed by flow cytometry. Because
these cells are present at the satellite cell position in skeletal
muscle tissue, are found in the SP, express satellite cell markers,
and remain tightly associated with myofibers during enzymatic
isolation, we propose that these cells represent a subset of satel-
lite cells and refer to this population as satellite-SP cells.
Satellite-SP Cells Express Pax7 and Have Distinct
Behavior in Culture
The presence of satellite-SP cells on intact myofibers allows
independent analysis of their behavior and comparison with
the general satellite cell population in culture. Distinct from the
major Syndecan-4+ population, where clusters of cells appearCell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc. 219
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Syndecan-4 SP Cells Engraft as Satellite CellsFigure 3. Satellite-SP Cells Express Pax7 and Exhibit Distinct Behaviors in Culture
Myofibers cultured for 6 days (A and B) retain single rare ABCG2+/Syndecan-4+ (red and green, respectively) satellite-SP cells (caret) surrounded by clusters of
ABCG2-/Syndecan-4+ satellite cells (arrowsmark some of the ABCG2–/Syndecan-4+ satellite cells). Following a 48 hr BrdUpulse and 48 hr chase, all satellite-SP
cells ([C–F], caret) and satellite cells ([C–F], arrows) are BrdU positive (red, [C]–[F], Syndecan-4 [blue], and ABCG2 [green]). After a 6 day chase (G)–(J), only
ABGG2+ satellite-SP cells (caret) retain BrdU (red), while satellite cells (arrows) are BrdU negative. Freshly isolated myofibers possess satellite-SP cells (caret
in [K]–[O]) expressing Pax7 ([M], red) in addition to Syndecan-4 ([K], white) and ABCG2 ([L], green). FACS-sorted satellite-SP cells (P) were either fixed and per-
meabilized, demonstrating that all satellite-SP (Syndecan-4+/ABCG2+/Sca1+) cells are Pax7+ ([Q], black histogram), or cultured for 5 days, fixed, and visualized
for myotubes (R) and stained for MyoD ([S], green) and Pax7 ([T], red). Boxed region in (R) and (S) identifies an unfused MyoD+/Pax7+ cell ([T], inset). Sorting
muscle SP cells by Hoescht dye exclusion (U) for Syndecan-4 immunoreactivity ([V], R1 Syndecan-4 and R2 Syndecan-4+muscle SP cells) followed by 3weeks
in culture (W and X) revealed that only Syndecan-4+ satellite-SP ([V], R2) cells spontaneously differentiated into myotubes (X). In (Q), the black histogram repre-
sents specific antibody immunoreactivity, and the gray histogram is the corresponding control. Scale bars represent 10 mm.following 6 days in culture, single satellite-SP cells appear sur-
rounded by Syndecan-4+ satellite cells (Figures 3A and 3B, caret
marks satellite-SP cell). A number of possibilities could explain
this observation, including (1) asymmetric cell division, (2) very
slow cell cycling, (3) enhanced migration of the satellite-SP cells
off of the myofibers, (4) enhanced cell death of satellite-SP cells,
or (5) a failure of satellite-SP cells to divide in culture. The first two
possibilities are not likely, as we did not observe satellite-SP
cells on the tissue culture plates adjacent to the myofibers, nor
did we observe apoptosis of satellite cells (data not shown). It
is also possible that the ABCG2 immunoreactivity is lost during
culture, and we cannot directly assess this possibility. To
demonstrate cell-cycle entry of satellite-SP cells, we employed
a BrdU pulse-chase assay, in which myofibers were cultured
for the first 48 hr after harvest in the presence of BrdU followed
by either a 48 hr or a 6 day chase in the absence of BrdU. Typi-
cally, Syndecan-4+ satellite cells on intact myofibers in culture
will begin DNA synthesis 8–12 hr following isolation and undergo
a synchronous division between 36 and 45 hr, with subsequent
cell divisions occurring much more rapidly at 10–12 hr (our220 Cell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc.unpublished data). All satellite cells (Figures 3C–3F, arrows)
and satellite-SP cells (Figures 3C–3F, carets) incorporate BrdU
during the first 48 hr in culture and retain label 48 hr later, indi-
cating that satellite-SP cells undergo a first cell division with
kinetics roughly similar to Syndecan-4+ cells. However,
following a 6 day chase in the absence of BrdU, Syndecan-4+
satellite cells continue to proliferate and dilute the BrdU label
(Figures 3G–3J, arrows), whereas all satellite-SP cells retain
BrdU, indicating that these cells cease cell division or cycle
very slowly (Figures 3G–3J, caret). Curiously, we rarely observe
ABCG2+/Syndecan-4+ doublets and typically find single iso-
lated cells (Figures 3A–3J). If this is the result of asymmetric
satellite-SP cell division giving rise to one daughter cell that
retains the parental phenotype, the other daughter would be pre-
dicted to proliferate and thereby dilute the BrdU label. This is
a possibility, since rare, asymmetric division of satellite cells
has been observed (Kuang et al., 2007), and the expression of
stem cell markers by the satellite-SP cells suggests that an
asymmetric cell division event could explain the predominance
of single satellite-SP cells.
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Syndecan-4 SP Cells Engraft as Satellite CellsFigure 4. Satellite-SP Cells Engraft into Myofibers and the Satellite Cell Position In Vivo
(A and B) Hindlimb skeletal muscle from Rosa26 mice was sorted for satellite-SP cells (A), Syndecan-4+ ([B], Syndecan-4+/ABCG2+/Sca1+, top box), or satellite
cells ([A], Syndecan-4+; [B], Syndecan-4+/ABCG2/Sca1, bottom box), and 2500 cells were transplanted into regenerating tibialis anterior muscle of different
host mice with 1.2% BaCl2.
(C and D) Representative epifluorescent images from cross-sections of transplanted and injured muscle depicting low numbers of b-galactosidase-expressing
myofibers with transplantation of 2500 satellite cells (C) and b-galactosidase+ myofibers in satellite-SP cell transplanted tissue (D) 30 days after regeneration
(asterisks mark centrally located nuclei).
(E) Scoring for donor-derived b-galactosidase+ myofibers following satellite-SP cell transplantation.
(F–I) 3D reconstruction of confocal images of donor-derived b-galactosidase+ ([F and I], green) satellite cells 30 days after transplantation of satellite-SP cells
([F–I], Laminin red; [G and I], Syndecan-4 white; [H and I], DAPI blue) with concurrent injury; insets are boxed. Scoring for donor-derived b-galactosidase+ satellite
cells (J) 30 days after transplantation of satellite-SP cells. In (A), hatched histogram represents Syndecan-4, and gray histogram is the control; Syndecan-4+ (S4+)
cells marked by bar. Scale bar in (D) represents 25 mm and in (I) represents 10 mm.To further define the satellite cell character of satellite-SP
cells, we asked if they express the paired box transcription factor
Pax7, which is considered a marker of quiescent satellite cells
and is required for satellite cell specification in vivo (Seale
et al., 2000). Satellite-SP cells on intact myofibers that stain posi-
tive for Syndecan-4 (Figure 3K) and ABCG2 (Figure 3L) appear
Pax7+ (Figures 3M and 3O). FACS-sorted satellite-SP cells
(Figure 3P) were Syndecan-4+ and stained positive for Pax7
when cytospun (Figure S2); when analyzed by FACS, essentially
all satellite-SP cells are Pax7+ (Figure 3Q), suggesting that these
cells are committed to the myogenic lineage.
Satellite-SP cells express satellite cell markers and remain
associated with myofibers, but we have not determined whether
these cells are capable of spontaneousmyogenic differentiation.
In previous reports, skeletal muscle SP cells have not exhibited
this potential and are only capable of initiating myogenesis
when cocultured with satellite cells or skeletal muscle cell lines
(Asakura et al., 2002). We reasoned that if satellite-SP cells
were the only SP cells capable of myogenesis, then their
myogenic phenotypes may have been overlooked in culture,
since they represent only a small percentage of the muscle-
derived SP population. Alternatively, myogenic commitment of
muscle SP cells by coculture with myogenic cell lines may repre-
sent a required community effect. Therefore, we asked if satel-
lite-SP cells are inherently myogenic in clonal cultures. FACS
sorted satellite-SP cells cultured in growth media for 5 days
differentiated into multinucleated myotubes (Figure 3R), whose
nuclei express MyoD (Figure 3S) and retain mononuclear
MyoD+/Pax7+ cells (Figures 3S and 3T, inset). As a further testto determine if satellite-SP cells, isolated by Hoechst dye exclu-
sion, are capable of myogenesis, muscle SP cells were sorted
into Syndecan-4+ and Syndecan-4 pools (Figures 3U and
3V), and the pools were individually cultured for 3 weeks in
stem cell media. As expected, Syndecan-4 muscle SP cells
fail to commit to a myogenic lineage (Figure 3W), while satel-
lite-SP cells spontaneously differentiated and fused intomultinu-
cleated myotubes (Figure 3X). Thus, when isolated from the bulk
of SP cells by dye exclusion or by FACS sorting, satellite-SP cells
are capable of spontaneousmyogenesis, supporting the hypoth-
esis that these cells are capable of commitment to the myogenic
lineage.
Satellite-SP Cells Are Myogenic Following
Transplantation
If satellite-SP cells function as a myogenic progenitor or satellite
stem cell, then we predict that they would produce satellite cell
progeny capable of incorporation into the satellite cell niche as
well as contributing myonuclei to myofibers. To address both
the myogenic and stem cell capabilities of satellite-SP cells
compared to satellite cells, we identified Syndecan-4+ cells by
FACS from a Rosa26 (Zambrowicz et al., 1997) donor mouse to
lineage mark cell progeny (Figure 4A), then sorted the Synde-
can-4+ cells into two separate pools (Figure 4B), the satellite-SP
cells (Syndecan-4+/ABCG2+/Sca1+) and satellite cells (Synde-
can-4+/ABCG-/Sca1). Tibialis anterior muscles of separate
host micewere injectedwith 2500 satellite-SP cells or 2500 satel-
lite cells in the presence of 1.2%BaCl2 to inducemuscle regener-
ation. The transplanted muscles were examined for donor cellCell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc. 221
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Syndecan-4 SP Cells Engraft as Satellite Cellscontribution 30 days following induced injury. Cross-sections
from the satellite cell transplant show evidence of regeneration
as indicated by centrally located nuclei (Figure 4C, asterisks),
but there is littledetectabledonorcell engraftment into themyofib-
ers and no detectable engraftment into the satellite cell niche
(Figure 4C, data not shown). In satellite-SP transplanted muscle,
b-galactosidase+ myofibers are numerous and clearly evident
(Figures 4D and 4E), suggesting engraftment of donor satellite-
SP cells. Moreover, b-galactosidase+ donor-derived cells
(Figure 4F) that express Syndecan-4 (Figure 4G) were readily
found in the host satellite cell niche located underneath the basal
lamina (Figures 4F–4I), demonstrating that satellite cells aswell as
myonuclei can be derived from satellite-SP cell progeny in vivo.
Satellite-SP cells contribute to myonuclei, as 30% of myofibers
were b-galactosidase+ and thus contained donor-derived nuclei
(Figure 4E, Table S2). Themajority of these fibers possessed cen-
trally located nuclei (Figure 4C, asterisk, Table S2), indicative of
regenerated tissue. Transplantation of satellite cells produced
few detectable b-galactosidase+ fibers (Figure 4C); however,
we did find centrally located nuclei (Figure 4C, asterisk), affirming
that the tissue was injured.
Engraftment of satellite-SP cells into the host tissue preferen-
tially engrafts into the satellite cell niche, as demonstrated by
the striking contribution of donor satellite cells to the regenerated
tissue (Figure 4J). We found that 75% of all satellite cells present
in the regenerated tibialis anterior muscle were donor-derived
cells (Figure 4J, Table S3) as they engrafted into the satellite
cell niche, were located underneath the basal lamina (Figures
4F–4I), and expressed the satellite cell marker Syndecan-4
(Figures 4G and 4I). The engraftment of satellite-SP cells demon-
strates that they robustly and preferentially contribute to the
satellite cell pool. Althoughwe found b-galactosidase expression
in myotubes, the capacity of the satellite-SP cells to differentiate
into muscle in vivo is not addressed by these experiments. To
determine if satellite-SP cells are capable of muscle differentia-
tion, satellite-SP cells from a ROSA26 mouse were isolated by
FACS as Syndecan-4+/ABCG2 +/Sca1+ and 2500 cells injected
into the tibialis anterior muscle of an mdx4cv mouse (Chapman
et al., 1989) in the presence of BaCl2 (Figures 5A and 5B). An
examination of muscle sections 30 days following engraftment
reveals extensive regeneration (Figure 5C, asterisks mark
centrally located nuclei), extensive contribution of Dystrophin
from the donor cells (Figure 5D), and localization of donor-
contributed Dystrophin inside the basal lamina (Figures 5E and
5F). Contribution of engrafted satellite-SP cells to themyonuclear
compartment inmdx4CVwas substantially greater than wild-type
transplants, in which 70% of the myofibers in the engrafted
muscle were Dystrophin+ (Figure 5G, Table S4).
Engraftment of satellite-SP cells differed from engraftment of
freshly isolated, CD34-enriched satellite cells, which require
injection into irradiated, immunodeficient mdx mice (Montarras
et al., 2005; Muskiewicz et al., 2005; Sacco et al., 2008) or
diseased (mdx) mice (Cerletti et al., 2008). Thus, satellite-SP cells
compete effectivelywith endogenous satellite cells since thehost
tissue is not irradiated to destroy the endogenous cells and injec-
tions are successful in wild-type regenerating muscle, not
diseased muscle tissue, where endogenous satellite cells may
be compromised. Together, our data show preferential engraft-
ment of satellite-SP cells into the satellite cell niche with efficien-222 Cell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc.cies not seen for any other cell types, suggesting the satellite-SP
cell may function as a satellite stem cell. To provide further
evidence in support of this hypothesis, we reinjured tibialis ante-
riormuscles inmdx4CVmiceengraftedwith 2500satellite-SPcells
from a ROSA26 mouse (Figures 6A–6C). Muscle sections were
examined for the contribution of donor cells to the satellite cell
and myonuclear compartments 30 days following reinjury.
Similar to the primary engraftment, reinjured muscle shows
extensive contribution of donor cells to themyonuclear compart-
ment demonstrated by b-galactosidase+ myofibers (Figure 6D).
Moreover, a large number of Syndecan-4+ cells are evident (Fig-
ure 6E) that are b-galactosidase+ (Figure 6F). A magnified 3D
reconstruction from a confocal series shows a donor-derived
satellite cell (Figure 6G, caret) and one endogenous satellite cell
(Figure 6H, arrow) in reinjured muscle (Figure 6I). We tested
the capacity of the donor-derived satellite cells in reinjured
Figure 5. Satellite-SP Cells Generate Dystrophin+ Fibers Following
Transplantation
Hindlimb skeletal muscle from Rosa26 mice was sorted for satellite-SP cells
(A) and Syndecan-4+ ([B], Syndecan-4+/ ABCG2+/Sca1+, box) and trans-
planted into tibialis anterior muscles of mdx4cv mice in the presence of 1.2%
BaCl2 to induce injury. (C–F) Representative epifluorescent images 30 days
following transplantation and injury depicting centrally located nuclei (aster-
isks) and Dystrophin+ fibers ([D–F], red). Scoring is for Dystrophin+ fibers (G)
30 days following transplantation of satellite-SP cells.
Cell Stem Cell
Syndecan-4 SP Cells Engraft as Satellite Cellsmdx4CV muscle to differentiate by explanting single myofibers,
allowing the myofiber-associated cells to migrate off of the fiber
into theculture dish.Donor-derived b-galactosidase+ cells differ-
entiated and fused into multinucleated myotubes in culture
(Figures 6J–6L), demonstrating the myogenic capacity of the
satellite-SP cells following two successive rounds of muscle
injury in themdx4CV mouse.
DISCUSSION
We have identified a subset of resident myogenic stem cells
distinct from the majority of the satellite cell population that
exhibit unique characteristics consistent with that of a satellite
cell progenitor population. These cells express the satellite cell
markers Pax7, Syndecan-3, and Syndecan-4; the SP marker
ABCG2; and Sca1. They can be found in muscle sections and
remain tightly associated withmyofibers upon isolation. Whether
isolated by dye exclusion or FACS sorted, these cells are
capable of spontaneous differentiation into skeletal muscle.
Unlike the majority of satellite cells, these cells possess an SP
Figure 6. Transplanted Satellite-SP Cells Are Found after Multiple
Rounds of Regeneration and Are Myogenic In Vitro
(A–C) Satellite-SP cells (A), Syndecan-4+ cells (B), and Syndecan-4+/
ABCG2+/Sca1+ cells were isolated from hindlimb skeletal muscle of Rosa26
mice and transplanted into mdx4cv tibialis anterior muscle. Following 30 days
of regeneration, muscle was either reinjured with 1.2% BaCl2 or explanted
to isolate myofibers (C).
(D–F) Representative epifluorescent images of reinjured tissue with continued
presence of donor-derived (b-galactosidase+, green [D and F]) Syndecan-4+
(red [E and F]) satellite cells.
(G–J) 3D reconstruction of confocal images of donor-derived (b-galactosi-
dase+, green) Syndecan-4+ (red) cells located beneath the basal lamina (Lam-
inin, white) 30 days following reinjury. Transplanted muscle fibers were were
explanted, and satellite cells cultured and allowed to differentiate. Donor-
derived, b-galactosidase+ (green [K and L]) cells formed myotubes.phenotype identified by Hoechst dye exclusion, express
ABCG2, and comprise 3%–10% of the Syndecan-4+ popula-
tion. When isolated, satellite-SP cells (Syndecan-4+/ABCG2+/
Sca1+) exhibit a robust engraftment into the host satellite cell
niche and generate myonuclear progeny that express muscle-
specific genes. Moreover, upon reinjury, the contribution of
donor-derived satellite-SP cells to the myonuclear and satellite
cell compartments in reinjured muscle was equivalent or better
than the initial engraftment, demonstrating the capacity of satel-
lite-SP cells to renew the satellite cell pool. Whereas engraftment
of CD34-enriched cells from muscle are capable of generating
satellite cell progeny (Montarras et al., 2005; Cerletti et al.,
2008; Sacco et al., 2008), satellite-SP cells are more efficient
than any other reported cell type in generating satellite cell
progeny when engrafted into host regenerating skeletal muscle.
Moreover, satellite-SP cells appear capable of extensive self-
renewal of the satellite cell pool in vivo, supporting our hypoth-
esis that they function as satellite cell progenitors. Because
these cells comprise a subpopulation of muscle SP cells, we
believe that theymay account for the variablemyogenic capacity
previously observed in cultures of muscle-derived SP cells (Asa-
kura et al., 2002; Gussoni et al., 1999) and the satellite cell
progenitor capacity observed in CD34-enriched satellite cells
(Montarras et al., 2005; Cerletti et al., 2008; Sacco et al., 2008).
Of particular interest is the observation that some of the skeletal
muscle SP cells are somitically derived (Schienda et al., 2006),
and it remains to be determined if the satellite-SP cells arise
from this population. We propose a model (Figure 7) whereby
satellite-SP cells function as myogenic progenitors or stem cells
for the resident satellite cell population. Satellite-SP cells acti-
vate and divide to produce satellite cell progeny; we have not
yet determined if satellite-SP cells constitute a distinct cell
lineage or if a satellite-SP cell can arise from a main population
satellite cell that is present in a specialized niche. The behavior
of the satellite-SP cells in intact myofiber cultures suggests
that the factors controlling their cell-cycle entry are distinct
from those of the majority of satellite cells, since they appear
to cycle once and then either exit the cell cycle completely or
cycle very slowly, a trait that has been ascribed to both stem
cells in general and myogenic stem cells in particular (Shinin
et al., 2006; Conboy et al., 2007). Future work is aimed at identi-
fying the factors necessary for satellite-SP cell proliferation,
determining whether these cells generate satellite cell progeny
Figure 7. Satellite-SP Cells Self-Renew and Generate Satellite Cell
Progeny
Satellite-SP cells (gray) may divide asymmetrically to produce a satellite-SP
cell and a satellite cell. Satellite cells are capable of symmetric division to
produce satellite cell progeny. It is not known if satellite-SP cells constitute
a lineage or arise from the interaction of a satellite cell with a specialized niche.Cell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc. 223
Cell Stem Cell
Syndecan-4 SP Cells Engraft as Satellite Cellsby an asymmetric division and identifying the source of satellite-
SP cells.
EXPERIMENTAL PROCEDURES
Mice
Mice were bred and housed according to National Institutes of Health (NIH)
guidelines for the ethical treatment of animals in a pathogen-free facility at
the University of Colorado. Wild-type mice were C57Bl/6xDBA2 (B6D2F1;
Jackson Labs); Rosa26 (B6;129S-Gt(ROSA)26Sor) (Zambrowicz et al., 1997)
andmdx4CV (Chapman et al., 1989) mice were obtained from Jackson Labora-
tory. Abcg2/GFP (Tadjali et al., 2006) mice were from Brian Sorrentino
(St. Jude Children’s Research Hospital). Cells or myofibers were harvested
from female mice 3–6 months old.
Cells and Myofibers
Bone marrow cells were flushed from femurs and resuspended at 106 cells/ml
in DMEM and 10% calf serum. Primary muscle cells were isolated from adult
mouse hindlimb muscle. Briefly, muscle was digested with type I collagenase
(Worthington), filtered, and recovered in F12-C and 15% horse serum and
0.5 nM FGF-2. SP cells were cultured in a-MEM media (Invitrogen) with 20%
FBS and 0.5 nM FGF-2. Unless otherwise noted, myofibers and associated
satellite cells were prepared as previously described (Cornelison et al., 2001)
and either fixed immediately in 4% paraformaldehyde or cultured in F12-C
and 15%horse serum and 0.5 nM FGF-2. As required, BrdU, at 10 mM (Sigma),
was added.
FACS
For SP profiles, bone marrow cells and primary muscle cells were processed
as described (Goodell et al., 1996). Briefly, following isolation, cells were incu-
bated 90 min at 37C in 5 mg/ml (bone marrow) or 7.5 mg/ml (muscle) Hoechst
33342 (Sigma). To delineate the SP gate, verapamil (Sigma) was added at
a final concentration of 50 mM. Profiles/sorts were generated on a MoFlo cell
sorter (DakoCytomation). For antibody staining, cells were incubated for
45 min at 4C with primary antibodies (at 1:100 unless otherwise noted) as
follows: mouse anti-ABCG2 (BCRP1) 5D3 (BD PharMingen), mouse anti-
ABCG2-PE (BCRP1) 5D3 (Chemicon), rat anti-CD45-FITC 30-F11 (BD Phar-
Mingen), rat anti-Gr-1-Alexa488 RB6-8C5 (BoiLegend), rat anti-Mac-1-FITC
M1/70 (Leinco Technologies), mouse anti-Pax7 (Developmental Studies
Hybridoma Bank) conjugated to mouse Fc-PE-680 (Molecular Probes) at 1:5,
rat anti-PECAM-FITC Mec13.3 (BD PharMingen), rat anti-Sca1-FITC E13-
161.7 (BD PharMingen), rabbit anti-Syndecan-3 (Cornelison et al., 2001),
chicken anti-Syndecan-4 (Cornelison et al., 2004) at 1:1500, and rat anti-
Thy-1-FITC 30-H12 (BioLegend). Secondary antibodies were (at 1:100 unless
otherwise noted) as follows: anti-chicken-Alexa488 (Molecular Probes) 1:500,
anti-chicken-PE (Open Biosystems), anti-mouseIgG-PE-Cy5 (Santa Cruz),
and anti-ratIgG-PE-Cy7 (Santa Cruz). Fluorescein diacetate (Sigma) was
used at a final concentration of 2 mg/ml. Caltat fix and perm was used for per-
meabilized cells. Profiles/sorts were generated using the MoFlo (DakoCyto-
mation) or FACScan (BD Biosciences) with background gates set such that
secondary antibodies alone, or isotype controls, yielded fewer than 0.5%posi-
tive events.
Immunofluorescence
Cells, myofibers, and sections were fixed in 4% paraformaldehyde. In addition
to the primary antibodies listed above, rabbit anti-galactosidase (Abcam,
1:1000), rat anti-BrdUBU1/75 (Serotec, 1:100), rabbit anti-Dystrophin (Abcam,
1:200), rat anti-laminin 4HB-2 (Sigma, 1:200), and rabbit anti-laminin (Sigma,
1:200) were used. Additional secondary antibodies were as follows: anti-
chicken-Alexa594 or 647 (Molecular Probes); anti-chicken-AMCA (Jackson
ImmunoResearch); anti-mouse-Alexa488 or 594 (Molecular Probes); anti-
mouseIgG1-FITC (SouthernBiotech); anti-mouseIgG2b-Texas Red (Southern-
Biotech); anti-rat-Alexa488, -594, or -647 (Molecular Probes); anti-rat-AMCA
(Jackson ImmunoResearch); and anti-rabbit-Alexa488, -594, or -647 (Molec-
ular Probes), all at 1:100, except Alexa probes were at 1:500. Epifluorescent
images were captured using a Nikon Eclipse E800 equipped with a Cooke
Sensicam digital camera and deconvoluted using Slidebook software (Intelli-224 Cell Stem Cell 4, 217–225, March 6, 2009 ª2009 Elsevier Inc.gent Imaging Innovations). Deconvoluted background fluorescence was
subtracted from the primary signal. Individual tiff files were exported from
Slidebook software. Confocal images and Z series stacks were captured
with a Leica TCS SP2 AOBS confocal microscope. Fluorescent images were
processed with either Leica software or Volocity (Improvision) to process
3D reconstructions.
Microarray
Cells were isolated from mouse hindlimb muscle and sorted for Syndecan-3/
Syndecan-4 expression as described above; sourcemuscles were either unin-
jured or injected with 1.2% BaCl2 24 hr prior to harvest to induce myonecrosis
(Caldwell et al., 1990). At least three independent age-matched animals were
analyzed per time point. Total RNA was isolated using a PicoPure RNA Isola-
tion Kit (Arcturus) followed by two rounds of linear T7-based amplification
(RiboAmp HA Kit, Arcturus) for an RNA equivalent to 5000 dual-positive cells
(based on the number of cells collected). Biotin-labeled antisense RNA was
generated with IVT Labeling Kit (Affymetrix), and labeled cRNA was quantified
and analyzed for size representation using a BioAnalyzer (Agilent). Labeled
cRNA (5 mg) was fragmented and hybridized to Affymetrix 430 v.2 mouse
microarrays at the University of Colorado Core facilities; chips were scanned
on a GeneChip Scanner 3000 (Affymetrix) and intensity data recovered in
GCOS (Affymetrix). CEL files from three replicate genechips were imported
directly into Spotfire (TIBCO) and normalized by GCRMA. ANOVA analysis
set at an FDR of 0.05% was used to identify differentially expressed probe
sets. Probe sets with R2-fold changes between uninjured and 24 hr injured
data sets were further identified by K-means and SOM clustering. Probe
sets with significant changes observed in satellite and stem cells were identi-
fied and plotted according to their relative expression.
Regeneration and Cell Transplants
To isolate cells from injured tissue, micewere anesthetized with isoflurane, and
tibialis anterior muscles were injected with 50 ml 1.2% BaCl2, followed with
a 24 hr recovery period. Muscles were processed for sorting and RNA extrac-
tion as described above. For transplantation studies, donor Syndecan-4+/
ABCG2+/Sca1+ and Syndecan-4+/ABCG2/Sca1 cells were isolated from
hindlimb muscles of Rosa26 mice. Host B6D2F1 mice were anesthetized with
isoflurane, and tibialis anterior muscles were injected with donor cells in 50 ml
1.2% BaCl2 followed with recovery periods of 30 days. Muscle tissue was
then harvested and processed for immunofluorescence as described above.
SUPPLEMENTAL DATA
The Supplemental Data include four tables, two figures, and Supplemental
References and can be found with this article online at http://www.cell.com/
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